MedTrace Logo

Treatment of Epidermoid Cysts

NCT05597995 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-10-28

No results posted yet for this study

Summary

The objective of this study is to determine the efficacy, safety, tolerability, and patient satisfaction associated with the treatment of epidermoid cysts with injected 1.5% sodium tetradecyl sulfate (STS) foam.

Conditions

  • Epidermoid Cyst

Interventions

DRUG

Sodium Tetradecyl Sulfate

subjects epidermoid cysts will be treated with 1.5% sodium tetradecyl sulfate foam

Sponsors & Collaborators

  • Goldman, Butterwick, Fitzpatrick and Groff

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2023-05-30
Completion
2023-05-30
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05597995 on ClinicalTrials.gov